SeqWell
PrivateLast Round
Series C
Extension
Feb 6, 2025
Total Funding Raised
$24.52M
Company Overview
SeqWell is a biotechnology company that develops and provides next-generation sequencing (NGS) library preparation technologies and kits. Founded in 2014, the company's mission is to simplify and improve NGS workflows, enabling scientists to conduct research more efficiently. Its proprietary plexWell and LongPlex platforms offer scalable solutions for multiplexing hundreds or thousands of samples for sequencing without the need for complex normalization steps. SeqWell's products are used in various applications, including synthetic biology, targeted sequencing, single-cell analysis, and genomics research across human, plant, animal, and microbial genomes. The company is privately held, backed by venture capital, and is headquartered in Beverly, Massachusetts.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SeqWell Comps
Public and private peers based on sector, stage, and business model.
SeqWell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Feb 6, 2025 | ||||
| Series C Extension | Sep 11, 2023 | ||||
| Series C | Apr 21, 2022 | ||||
| Series B | Jan 14, 2020 | ||||
| Series A Extension | May 4, 2017 | ||||
Seed | Jul 1, 2016 |
SeqWell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Research Corporation Technologies | Series C, Series B |
| BroadOak Fund | Series B |
| BroadOak Capital Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Launched MosaiX, a next-generation library prep kit for high-throughput genomics.
- Jan 6, 2026
Launched the AgriPrep Library Prep Kit, expanding its TnX transposase portfolio.
SeqWell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SeqWell's valuation, stock price, and market status.
